Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Conscious and deep sedation drugs in pediatric dentistry: a systematic review of randomized controlled trials (2019–2024)
1Department of Dentistry, School of Medicine, CEU San Pablo University, 28668 Madrid, Spain
DOI: 10.22514/jocpd.2026.031 Vol.50,Issue 2,March 2026 pp.14-22
Submitted: 15 August 2025 Accepted: 29 October 2025
Published: 03 March 2026
*Corresponding Author(s): Clara Sandibel Garcete Delvalle E-mail: clara.garcetedelvalle@ceu.es
Background: Dental anxiety in children is a common issue that hinders dental treatment, generates negative experiences, and perpetuates fear. This highlights the importance of finding effective solutions. Conscious and/or deep sedation techniques are key tools to improve the pediatric patient’s experience and facilitate complex procedures. However, their application requires careful analysis due to the wide variety of available protocols, recommendations and administration routs. Methods: A systematic review was conducted following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The electronic search for this review was conducted from October to January (2024–2025). Articles were selected from three databases: PubMed, Scopus, and Web of Science. Specific filters were applied for each database. Eight terms were used for the search strategy and selection criteria was followed. Studies that performed any dental treatment on pediatric patients aged 2 to 12 years who underwent conscious or deep sedation to reduce their anxiety. The risk of biased of the selected articles was assessed. Results: The initial electronic search generated 1697 titles from the MEDLINE/PubMed database, 1563 from Web of Science, and 1437 from Scopus, which were lateter filtered and duplicates eliminated. After analyzing the titles and abstracts of 196 articles, 14 Randomized Controlled Trials (RCTs) that were published during the last 5 years were selected for this review. Conclusions: The fastest onset of action is determined by the route of administration. Reported adverse effects were not statistically significant. Nitrous oxide shows the fastest recovery, but drug selection should always be based on the type of dental procedure, its duration, and the child’s specific needs. Further research is needed to evaluate parents’ level of satisfaction. The PROSPERO Registration: The review was registered into PROSPERO (registration number: CRD420250637249).
Pediatric dentistry; Anti-anxiety agents; In-office sedation
Clara Sandibel Garcete Delvalle,Marisa Navarro Martínez,Judit Carrasco Vivó,Marta Rodríguez-Villa,Eva María Martínez Pérez,Marta Bruna Del Cojo. Conscious and deep sedation drugs in pediatric dentistry: a systematic review of randomized controlled trials (2019–2024). Journal of Clinical Pediatric Dentistry. 2026. 50(2);14-22.
[1] Santiago EP, Brito T de S, Almeida SA. Dentistphobia and the conduct of the dentist: an integrative review of the literature. Facit Business and Technology Journal. 2021; 1: 103–117.
[2] Baier K, Milgrom P, Russell S, Mancl L, Yoshida T. Children’s fear and behavior in private pediatric dentistry practices. Pediatric Dentistry. 2004; 26: 316–321.
[3] Gao F, Wu Y. Procedural sedation in pediatric dentistry: a narrative review. Frontiers in Medicine. 2023; 10: 1186823.
[4] Ashley PF, Chaudhary M, Lourenço-Matharu L. Sedation of children undergoing dental treatment. Cochrane Database of Systematic Reviews. 2018; 12: CD003877.
[5] Arenas M, Barbería E, Marotom M, Gómez B. Paternal demand of paediatric dental treatment using general anaesthesia: a surprising reality. RCOE. 2006; 11: 351–356. (In Spanish)
[6] Ansari G, Toomarian L, Masoum T, Shayeghi S, Eftekhar L. Evaluation of the sedative effect of intranasal versus intramuscular ketamine in 2–6-year-old uncooperative dental patients. Dental and Medical Problems. 2024; 61: 35–41.
[7] Clinical Affairs Committee–Behavior Management Subcommittee, American Academy of Pediatric Dentistry. Guideline on behavior guidance for the pediatric dental patient. Pediatric Dentistry. 2015; 37: 57–70.
[8] Zhang Q, Deng X, Wang Y, Huang R, Yang R, Zou J. Postoperative complications in Chinese children following dental general anesthesia: a cross-sectional study. Medicine. 2020; 99: e23065.
[9] Álvarez AM, Álvarez M. Oral sedation: clinical foundations for its application in dentistry. CES Odontología. 2006; 19: 61–73. (In Spanish)
[10] Salerno C, Cirio S, Zambon G, D’Avola V, Parcianello RG, Maspero C, et al. Conscious sedation for dental treatments in subjects with intellectual disability: a systematic review and meta-analysis. International Journal of Environmental Research and Public Health. 2023; 20: 1779.
[11] Lee R, Wang K, Forsyth A, Garcia M, Scott J, Nelson T. The effect of temperament on outcomes of opioid and non-opioid pediatric dental sedation. Journal of Dentistry for Children. 2024; 91: 18–24.
[12] Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. The BMJ. 2021; 372: n71.
[13] Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al.; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. The BMJ. 2011; 343: d5928.
[14] Heath A, Rios JD, Pullenayegum E, Pechlivanoglou P, Offringa M, Yaskina M, et al.; PERC-KIDSCAN Ketodex Study Group. The intranasal dexmedetomidine plus ketamine for procedural sedation in children, adaptive randomized controlled non-inferiority multicenter trial (Ketodex): a statistical analysis plan. Trials. 2021; 22: 15.
[15] ElKhatib AA, Ghoneim TAM, Dowidar KML, Wahba NA. Effect of Dexmedetomidine with or without Midazolam during procedural dental sedation in children: a randomized controlled clinical trial. BMC Oral Health. 2024; 24: 1298.
[16] El-Rouby SH, O Crystal Y, M Elshafie A, A Wahba N, El-Tekeya MM. The effect of dexmedetomidine-ketamine combination versus dexmedetomidine on behavior of uncooperative pediatric dental patients: a randomized controlled clinical trial. Journal of Applied Oral Science. 2024; 32: e20240057.
[17] El-Rouby SH, Crystal YO, Elshafie AM, Wahba NA, El-Tekeya MM. Effectiveness of buccal administration of dexmedetomidine and ketamine combination in paediatric dental sedation: a randomized controlled clinical trial. International Journal of Paediatric Dentistry. 2025; 35: 359–368.
[18] Janiani P, Gurunathan D, Nuvvula S. Influence of temperament on the acceptance of two conscious sedation techniques in toddlers undergoing dental treatment: a randomised cross over trial. Pain Research and Management. 2023; 2023: 6655628.
[19] Shaat MA, Bakry NS, Elshafie AM, Talaat DM. Intranasal versus sublingual route of dexmedetomidine sedation in paediatric dentistry: a randomized controlled clinical trial. International Journal of Paediatric Dentistry. 2022; 32: 232–239.
[20] Hammadyeh AR, Altinawi MK, Rostom F. Comparison of two intravenous sedation techniques for use in pediatric dentistry: a randomized controlled trial. Dental and Medical Problems. 2019; 56: 337–341.
[21] Haider K, Mittal N, Srivastava B, Gupta N. A double-blind randomized controlled trial to compare the safety and efficacy of dexmedetomidine alone and in combination with ketamine in uncooperative and anxious paediatric dental patients requiring pulpectomy. European Archives of Paediatric Dentistry. 2022; 23: 465–473.
[22] Rehman F, Goyal A, Gauba K, Jain K, Kapur A. Safety and efficacy of IV dexmedetomidine as an adjunct to propofol to sedate anxious and uncooperative pediatric dental patients: a randomized controlled trial. Journal of Clinical Pediatric Dentistry. 2021; 45: 428–432.
[23] Dubey B, Singh N, Kumar S. Comparison of intranasal ketamine with intranasal midazolam and dexmedetomidine combination in pediatric dental patients for procedural sedation: a crossover study. Journal of Indian Society of Pedodontics and Preventive Dentistry. 2024; 42: 217–225.
[24] Nie J, Chen C, Xie J, Ding G. Oral midazolam vs. intranasal dexmedetomidine plus oral midazolam for sedation of pediatric outpatients: a double-blinded randomized controlled trial. BMC Anesthesiology. 2023; 23: 341.
[25] Alhaidari RI, AlSarheed M, Sheta SA, Aldhubaiban M. Intranasal fentanyl combined with oral midazolam for pediatric dental sedation: a controlled randomized blinded crossover clinical trial. Pediatric Dentistry. 2022; 44: 255–260.
[26] Janiani P, Gurunathan D, Manohar R. Comparative evaluation of intranasal dexmedetomidine, intranasal midazolam, and nitrous oxide for conscious sedation of anxious children undergoing dental treatment: a randomized cross-over trial. Journal of Indian Society of Pedodontics and Preventive Dentistry. 2024; 42: 141–148.
[27] Isık G, Alpay N, Daglioglu G, Ciftci V. Effects of propofol, ketamine-propofol mixture in pediatric dental patients undergoing intravenous sedation: a clinical study. Scientific Reports. 2024; 14: 11806.
[28] Singh C, Pandey RK, Saksena AK, Chandra G. A comparative evaluation of analgo-sedative effects of oral dexmedetomidine and ketamine: a triple-blind, randomized study. Pediatric Anesthesia. 2014; 24: 1252–1259.
[29] Coté CJ, Wilson S; American Academy of Pediatrics; American Academy of Pediatric Dentistry. Guidelines for monitoring and management of pediatric patients before, during, and after sedation for diagnostic and therapeutic procedures. Pediatrics. 2019; 143: e20191000.
[30] Bastarrechea Milián M de las M, Rodríguez Soto A, Morales Navarro D. Medical risk in dental patients according to the ASA classification. Revista Habanera de Ciencias Médicas. 2020; 19: e3032.
[31] Garret-Bernardin A, Festa P, Matarazzo G, Vinereanu A, Aristei F, Gentile T, et al. Behavioral modifications in children after repeated sedation with nitrous oxide for dental treatment: a retrospective study. International Journal of Environmental Research and Public Health. 2023; 20: 4037.
Top